生物活性 | |||
---|---|---|---|
描述 | Mito-LND (Mito-Lonidamine) is an orally administered, mitochondria-focused inhibitor of oxidative phosphorylation (OXPHOS). It disrupts mitochondrial bioenergetics, promotes the production of reactive oxygen species, and triggers autophagic cell death in lung cancer cells[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.25mL 0.25mL 0.12mL |
6.24mL 1.25mL 0.62mL |
12.47mL 2.49mL 1.25mL |
参考文献 |
---|